KIT and PDGFRA activating mutations are mutually exclusive events in GIST that promote the constitutive activation of the receptors and the downstream signaling pathways, resulting in aberrant cell proliferation and apoptosis [2]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.